Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.
Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.
复制标题
在PTEN灭活的子宫内膜中转化生长因子-β受体1的条件废除可促进小鼠的子宫内膜癌进展。
DOI:
10.1002/path.4930
复制
发表时间:
2017-09
期刊:
影响因子:
--
通讯作者:
Li Q
中科院分区:
文献类型:
--
作者:
Gao Y;Lin P;Lydon JP;Li Q
Although a putative role for TGF beta (TGFB) signaling in the pathogenesis of human endometrial cancer has long been proposed, the precise function of TGFB signaling in the development and progression of endometrial cancer remains elusive. Depletion of PTEN in the mouse uterus causes endometrial cancer. To identify the potential role of TGFB signaling in endometrial cancer, we simultaneously deleted TGFB receptor 1 (Tgfbr1) and Pten in the mouse uterus using Cre-recombinase driven by the progesterone receptor (termed Ptend/d; Tgfbr1d/d). We found that Ptend/d; Tgfbr1d/d mice developed severe endometrial lesions that progressed more rapidly compared with those resulting from conditional deletion of Pten alone, suggesting that TGFB signaling synergizes with PTEN to suppress endometrial cancer progression. Remarkably, the Ptend/d; Tgfbr1d/d mice developed distant pulmonary metastases, leading to significantly reduced life span. The development of metastasis and accelerated tumor progression in Ptend/d; Tgfbr1d/d mice are associated with increased production of pro-inflammatory chemokines, enhanced cancer cell motility evidenced by myometrial invasion and disruption, and altered tumor microenvironment characterized by recruitment of tumor-associated macrophages. Thus, conditional deletion of Tgfbr1 in PTEN-inactivated endometrium leads to a disease that recapitulates invasive and lethal human endometrial cancer. This mouse model may be valuable for preclinical testing of new cancer therapies, particularly those targeting metastasis, one of the hallmarks of cancer and a major cause of death in endometrial cancer patients.
登录
查看更多内容
DOI:
10.4049/jimmunol.179.7.4849
发表时间:
2007-10-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Duchene J;Lecomte F;Ahmed S;Cayla C;Pesquero J;Bader M;Perretti M;Ahluwalia A
通讯作者:
Ahluwalia A
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
--
作者:
Gao Y;Vincent DF;Davis AJ;Sansom OJ;Bartholin L;Li Q
通讯作者:
Li Q
影响因子:
8
作者:
Kim, T. H.;Franco, H. L.;Jung, S. Y.;Qin, J.;Broaddus, R. R.;Lydon, J. P.;Jeong, J-W
通讯作者:
Jeong, J-W
DOI:
10.1016/0960-0760(92)90256-i
发表时间:
1992-06-01
影响因子:
4.1
作者:
ANZAI, Y;GONG, YW;GURPIDE, E
通讯作者:
GURPIDE, E